Source: Annual Congress 2010 - Pulmonary circulation III
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. C. Seyhan, I. Önür, S. Sökücü, S. Altin, R. Gelisgen, H. Uzun, A. Akbas, S. Tural Önür (Istanbul, Turkey). Relation of troponin and hert type fatty acid protein (H-FABP) levels to echocardiographic and cardiac infarction injury score (CIS) with patients with prespiratory insufficiency due to COPD attack. Eur Respir J 2010; 36: Suppl. 54, 1152

Member's Comments

No comment yet.

Related content which might interest you: The prognostic value of elevated levels of troponin I (Tn I) and heart-type fatty acid binding protein (H-FABP) in hospitalized COPD patients with acute respiratory failure (ARF) Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Right heart dysfunction (RHD) in patients with acute pulmonary embolism (PE): correlation between distribution of clots, troponin I and prognosis Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic obstructive pulmonary disease? Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Heart-type fatty acid binding protein (H-FABP) and brain natriuretic peptide-fragment (BNP-fragment) in COPD patients with pneumonia Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Prognostic value of echocardiography, BNP and cardiac troponin I (cTnI) in normotensive patients with pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005 C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Underlying ischaemic heart disease assessed by cardiac infarction injury score (CIIS) is under-recognised in our patients hospitalised for COPD exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Prognostic value of high troponin levels in acute COPD attack patients with respiratory insufficiency Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Prognostic value of right ventricular systolic dysfunction in patients with chronic obstructive pulmonary disease after ST-segment elevation myocardial infarction (STEMI). Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 The correlation of echocardiographic findings with BNP, blood uric acid and CPR in OSAS patients with manifest right cardiac pathologies Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD Source: Eur Respir J 2012; 39: 1097-1103 Year: 2012 Is a cardiopulmonary exercise test (CPET) associated with an increase in high sensitivity cardiac troponin T (hs-cTnT) levels in patients with COPD? Source: International Congress 2017 – Lung function practice in daily life Year: 2017 High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Exercise induced elevation of high-sensitive troponin T serum levels in patients with pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Relationships between elevated cardiac troponin levels in COPD exacerbations and subsequent cardiac investigation and management Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Myocardial dysfunction in patients (pts) after severe coronavirus disease (COVID-19) Source: Virtual Congress 2021 – Imaging in COVID-19 Year: 2021 Comparative analysis of global longitudinal strain in patients with ST-segment elevation myocardial infarction (STEMI) with and without concomitant COPD. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Current trends in the course, treatment, and outcomes of ST-segment elevation myocardial infarction (STEMI) in patients with COPD. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011